Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 027510/0478 | |
| Pages: | 7 |
| | Recorded: | 01/10/2012 | | |
| Attorney Dkt #: | 315137-2000 |
| Conveyance: | MERGER (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
7
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/18/2011
|
Application #:
|
10980211
|
Filing Dt:
|
11/02/2004
|
|
Publication #:
|
|
Pub Dt:
|
07/21/2005
| | | | |
|
Title:
|
STABILIZED APTAMERS TO PLATELET DERIVED GROWTH FACTOR AND THEIR USE AS ONCOLOGY THERAPEUTICS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/28/2010
|
Application #:
|
11058134
|
Filing Dt:
|
02/14/2005
|
|
Publication #:
|
|
Pub Dt:
|
01/26/2006
| | | | |
|
Title:
|
APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/26/2009
|
Application #:
|
11318227
|
Filing Dt:
|
12/22/2005
|
|
Publication #:
|
|
Pub Dt:
|
05/18/2006
| | | | |
|
Title:
|
APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/25/2009
|
Application #:
|
11354657
|
Filing Dt:
|
02/14/2006
|
|
Publication #:
|
|
Pub Dt:
|
03/01/2007
| | | | |
|
Title:
|
APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/07/2012
|
Application #:
|
11884411
|
Filing Dt:
|
08/26/2008
|
|
Publication #:
|
|
Pub Dt:
|
03/10/2011
| | | | |
|
Title:
|
APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12224708
|
Filing Dt:
|
04/02/2009
|
|
Publication #:
|
|
Pub Dt:
|
10/29/2009
| | | | |
|
Title:
|
Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/07/2014
|
Application #:
|
13235222
|
Filing Dt:
|
09/16/2011
|
|
Publication #:
|
|
Pub Dt:
|
07/05/2012
| | | | |
|
Title:
|
Stabilized Aptamers To Platelet Derived Growth Factor And Their Use As Oncology Therapeutics
|
|
|
Assignee
|
|
|
|
|
| 601 MONTGOMERY STREET, SUITE 2020 |
| ARCHEMIX LLC/ARCHEMIX LIQUIDATING TRUST, C/O SHAREHOLDER REPRESENTATIVE SERVICES LLC, ATTN: MANAGING DIRECTOR |
| SAN FRANCISCO, CALIFORNIA 94111 |
|
|
Correspondence name and address
|
| |
MATTHEW E. LANGER
|
| |
777 6TH STREET, NW
|
| |
WASHINGTON, DC 20001
|
Search Results as of:
06/01/2024 06:14 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
